For example, its down-regulation is reported to sensitize glioma cells to TRAIL [23] and 2-deoxy-D-glucose [20], and to augment the effect of inhibiting growth factor receptor signaling in breast cancer cells [24]. The gene discussed is TNFSF10; the disease is breast cancer.